/clinical/,/clinical/cckm-tools/,/clinical/cckm-tools/content/,/clinical/cckm-tools/content/beacon-protocols/,/clinical/cckm-tools/content/beacon-protocols/supportive-care/,

/clinical/cckm-tools/content/beacon-protocols/supportive-care/name-122942-en.cckm

201711331

page

100

UWHC,UWMF,

Tools,

Clinical Hub,UW Health Clinical Tool Search,UW Health Clinical Tool Search,Beacon Protocols,Supportive Care

CSC SC Goserelin (Zoladex) 3.6 mg Monthly X 12 Ver 11-20-17 (HL 1879)

CSC SC Goserelin (Zoladex) 3.6 mg Monthly X 12 Ver 11-20-17 (HL 1879) - Clinical Hub, UW Health Clinical Tool Search, UW Health Clinical Tool Search, Beacon Protocols, Supportive Care


CSC SC GOSERELIN (ZOLADEX) 3.6 MG MONTHLY X 12 VER: 11-20-17 –  Properties
Cycle 1 –  11/22/2017 through 12/19/2017 (28 days), Planned
Day 1, Cycle 1 –  Planned for 11/22/2017
Pre-Medications
lidocaine 1 % vial
1-5 mL, Subcutaneous, ONCE, 1 dose Starting when released
Supportive Care Medications
goserelin (ZOLADEX) drug implant NF 3.6 mg
3.6 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 2 –  12/20/2017 through 1/16/2018 (28 days), Planned
Day 1, Cycle 2 –  Planned for 12/20/2017
Pre-Medications
lidocaine 1 % vial
1-5 mL, Subcutaneous, ONCE, 1 dose Starting when released
Supportive Care Medications
goserelin (ZOLADEX) drug implant NF 3.6 mg
3.6 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 3 –  1/17/2018 through 2/13/2018 (28 days), Planned
Day 1, Cycle 3 –  Planned for 1/17/2018
Pre-Medications
lidocaine 1 % vial
1-5 mL, Subcutaneous, ONCE, 1 dose Starting when released
Supportive Care Medications
goserelin (ZOLADEX) drug implant NF 3.6 mg
3.6 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 4 –  2/14/2018 through 3/13/2018 (28 days), Planned
Day 1, Cycle 4 –  Planned for 2/14/2018
Pre-Medications
lidocaine 1 % vial
1-5 mL, Subcutaneous, ONCE, 1 dose Starting when released
Supportive Care Medications
goserelin (ZOLADEX) drug implant NF 3.6 mg
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
ZZtestonc,Andrew [2428787]
11/22/2017 12:49:10 PM Page 1 of 4
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised: 11/2017CCKM@uwhealth.org

3.6 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 5 –  3/14/2018 through 4/10/2018 (28 days), Planned
Day 1, Cycle 5 –  Planned for 3/14/2018
Pre-Medications
lidocaine 1 % vial
1-5 mL, Subcutaneous, ONCE, 1 dose Starting when released
Supportive Care Medications
goserelin (ZOLADEX) drug implant NF 3.6 mg
3.6 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 6 –  4/11/2018 through 5/8/2018 (28 days), Planned
Day 1, Cycle 6 –  Planned for 4/11/2018
Pre-Medications
lidocaine 1 % vial
1-5 mL, Subcutaneous, ONCE, 1 dose Starting when released
Supportive Care Medications
goserelin (ZOLADEX) drug implant NF 3.6 mg
3.6 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 7 –  5/9/2018 through 6/5/2018 (28 days), Planned
Day 1, Cycle 7 –  Planned for 5/9/2018
Pre-Medications
lidocaine 1 % vial
1-5 mL, Subcutaneous, ONCE, 1 dose Starting when released
Supportive Care Medications
goserelin (ZOLADEX) drug implant NF 3.6 mg
3.6 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 8 –  6/6/2018 through 7/3/2018 (28 days), Planned
Day 1, Cycle 8 –  Planned for 6/6/2018
Pre-Medications
lidocaine 1 % vial
1-5 mL, Subcutaneous, ONCE, 1 dose Starting when released
Supportive Care Medications
goserelin (ZOLADEX) drug implant NF 3.6 mg
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
ZZtestonc,Andrew [2428787]
11/22/2017 12:49:10 PM Page 2 of 4
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
11/2017CCKM@uwhealth.org

3.6 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 9 –  7/4/2018 through 7/31/2018 (28 days), Planned
Day 1, Cycle 9 –  Planned for 7/4/2018
Pre-Medications
lidocaine 1 % vial
1-5 mL, Subcutaneous, ONCE, 1 dose Starting when released
Supportive Care Medications
goserelin (ZOLADEX) drug implant NF 3.6 mg
3.6 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 10 –  8/1/2018 through 8/28/2018 (28 days), Planned
Day 1, Cycle 10 –  Planned for 8/1/2018
Pre-Medications
lidocaine 1 % vial
1-5 mL, Subcutaneous, ONCE, 1 dose Starting when released
Supportive Care Medications
goserelin (ZOLADEX) drug implant NF 3.6 mg
3.6 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 11 –  8/29/2018 through 9/25/2018 (28 days), Planned
Day 1, Cycle 11 –  Planned for 8/29/2018
Pre-Medications
lidocaine 1 % vial
1-5 mL, Subcutaneous, ONCE, 1 dose Starting when released
Supportive Care Medications
goserelin (ZOLADEX) drug implant NF 3.6 mg
3.6 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 12 –  9/26/2018 through 10/23/2018 (28 days), Planned
Day 1, Cycle 12 –  Planned for 9/26/2018
Pre-Medications
lidocaine 1 % vial
1-5 mL, Subcutaneous, ONCE, 1 dose Starting when released
Supportive Care Medications
goserelin (ZOLADEX) drug implant NF 3.6 mg
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
ZZtestonc,Andrew [2428787]
11/22/2017 12:49:10 PM Page 3 of 4
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
11/2017CCKM@uwhealth.org

3.6 mg, Subcutaneous, ONCE, 1 dose Starting when released
ZZtestonc,Andrew [2428787]
11/22/2017 12:49:10 PM Page 4 of 4
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
11/2017CCKM@uwhealth.org